Astrana Health (NASDAQ:ASTH) Issues FY24 Earnings Guidance

Astrana Health (NASDAQ:ASTHGet Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.28 to $1.52 for the period, compared to the consensus estimate of $1.60. The company issued revenue guidance of $1.65 billion to $1.85 billion, compared to the consensus revenue estimate of $1.76 billion.

Astrana Health Stock Down 1.0 %

Shares of ASTH stock traded down $0.39 on Tuesday, reaching $37.93. The company had a trading volume of 125,521 shares, compared to its average volume of 153,978. The firm has a market capitalization of $2.13 billion, a PE ratio of 28.74, a PEG ratio of 1.20 and a beta of 1.12. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.11 and a quick ratio of 2.11. The firm has a 50-day simple moving average of $40.47. Astrana Health has a one year low of $28.86 and a one year high of $45.71.

Astrana Health (NASDAQ:ASTHGet Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.17 by $0.09. The business had revenue of $353.00 million during the quarter, compared to the consensus estimate of $341.17 million. Astrana Health had a net margin of 4.49% and a return on equity of 11.52%. The firm’s revenue was up 20.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.02 EPS. On average, sell-side analysts forecast that Astrana Health will post 1.65 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on ASTH shares. Truist Financial upped their target price on Astrana Health from $41.00 to $44.00 and gave the stock a hold rating in a report on Friday, March 1st. Jefferies Financial Group initiated coverage on Astrana Health in a research note on Monday, February 26th. They issued a buy rating and a $50.00 price objective for the company.

Check Out Our Latest Stock Analysis on ASTH

Astrana Health Company Profile

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Featured Articles

Earnings History and Estimates for Astrana Health (NASDAQ:ASTH)

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.